NCT04694924Recruiting
Prospective Prostate Cancer and Patient-reported Outcomes Registry
Promoting Quality of Care: a Prospective Cohort Study of Localized and Locally Advanced Prostate Cancer Patients
Source: ClinicalTrials.gov · Last updated 22 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the use of a digital solution, integrated into the electronic health record, for prospective and structured reporting of clinical and patient-reported outcomes for patients diagnosed with localized or locally advanced prostate cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 24 Dec 2020
- Start date
- 1 Oct 2020
- Primary completion date
- Oct 2030
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Diseases
- Prostate cancer
- NCT number
- NCT04694924
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 1 Oct 2020 to the primary completion date, Oct 2030
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with prior treatment for prostate malignancies will be excluded.
Other illness
- Dementia, mental alteration, or psychiatric pathology that can compromise informed consent from the patient and/ or adherence to the protocol and the monitoring of the trial
Other
- Patients who cannot submit themselves to following the protocol for psychological reasons, social, family, or geographical.
- Persons deprived of liberty or under guardianship
Who the study is looking for
- Pathology confirmed diagnosis of localized or locally advanced prostate cancer
- Being able to speak, read and understand Dutch, French, or English
- Each patient (or their legally acceptable representative) must sign an informed consent form (ICF) indicating that he understands the purpose of, and is willing to participate in the study.
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Az Sint Jan Brugge Coordinator of this site? Confirm its status | Bruges | Belgium | Recruiting |
| AZ Sint-Blasius Coordinator of this site? Confirm its status | Dendermonde | Belgium | Recruiting |
| AZ Groeninge, Kortrijk Coordinator of this site? Confirm its status | Kortrijk | Belgium | Recruiting |
| University Hospitals Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.